Antidepressant Effect of Lithium in Patients with Systemic Lupus Erythematosus and Cerebral Infarction, Treated with Corticosteroid
- 2 January 1994
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 164 (1) , 109-111
- https://doi.org/10.1192/bjp.164.1.109
Abstract
Two depressive patients with systemic lupus erythematosus (SLE) and cerebral infarction, while being treated with corticosteroid, are described. In both cases, lithium was remarkably effective and no severe side-effects occurred. These findings suggest that lithium can be a useful antidepressant agent in the treatment of depressive SLE patients.Keywords
This publication has 11 references indexed in Scilit:
- Lithium chloride stimulates catecholamine synthesis and secretion in cultured bovine adrenal medullary cellsBiological Psychiatry, 1992
- Lithium Augmentation of TricyclicsThe British Journal of Psychiatry, 1986
- Reduced 5-hydroxytryptamine-dependent behaviour in rats following chronic corticosterone treatmentBrain Research, 1985
- Short-term lithium administration enhances serotonergic neurotransmission: Electrophysiological evidence in the rat CNSEuropean Journal of Pharmacology, 1985
- Post-stroke depressive disorders: a follow-up study of 103 patients.Stroke, 1982
- Controlled Studies of the Acute Antidepressant Effects of LithiumThe British Journal of Psychiatry, 1979
- Presentation of the Steroid PsychosesJournal of Nervous & Mental Disease, 1979
- Lithium Prophylaxis of Corticotropin-lnduced PsychosisPublished by American Medical Association (AMA) ,1979
- Lithium for Steroid-Induced PsychosisNew England Journal of Medicine, 1978
- PSYCHIATRIC ASPECTS OF SYSTEMIC LUPUS ERYTHEMATOSUSActa Psychiatrica Scandinavica, 1969